MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation

EMBO Journal

Volumn 24, Issue 18, 2005, Pages 3279-3290

  Wang, Chuangui ^a   Ivanov, Alexey ^b   Chen, Lihong ^a   Fredericks, William J ^b   Seto, Ed ^a   Rauscher III, Frank J ^b   Chen, Jiandong ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

Acetylation; ARF; KAP1; MDM2; p53

Indexed keywords

ARF PROTEIN; DNA; HISTONE DEACETYLASE 1; PROTEIN; PROTEIN KAP1; PROTEIN MDM2; PROTEIN P53; RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL NUCLEUS; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; TRANSCRIPTION INITIATION; UBIQUITINATION;

ACETYLATION; CELL LINE; CELL NUCLEUS; DNA; DNA DAMAGE; DNA-BINDING PROTEINS; HISTONE DEACETYLASES; HUMANS; MUTATION; NUCLEAR PROTEINS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

EID: 25144496653     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600791     Document Type: Article

References (46)

1. Aslanian A, Iaquinta PJ, Verona R, Lees JA (2004) Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev 18: 1413-1422
2. Blattner C, Hay T, Meek DW, Lane DP (2002) Hypophosphorylation of Mdm2 augments p53 stability. Mol Cell Biol 22: 6170-6182
3. Cammas F, Mark M, Dolle P, Dierich A, Chambon P, Losson R (2000) Mice lacking the transcriptional corepressor TIF1beta are defective in early postimplantation development. Development 127: 2955-2963
4. Chen J, Lin J, Levine AJ (1995) Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol Med 1: 142-152
5. Chen J, Marechal V, Levine AJ (1993) Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol 13: 4107-4114
6. Chen L, Chen J (2003) MDM2-ARF complex regulates p53 sumoylation. Oncogene 22: 5348-5357
7. De Graaf P, Little NA, Ramos YF, Meulmeester E, Letteboer SJ, Jochemsen AG (2003) Hdmx protein stability is regulated by the ubiquitin ligase activity of mdm2. J Biol Chem 278: 38315-38324
8. Freedman DA, Epstein CB, Roth JC, Levine AJ (1997) A genetic approach to mapping the p53 binding site in the MDM2 protein. Mol Med 3: 248-259
9. Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang XP, Neilson EG, Rauscher FJ (1996) KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev 10: 2067-2078
10. Gronroos E, Terentiev AA, Punga T, Ericsson J (2004) YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci USA 101: 12165-12170
11. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Livingston DM (2003) Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300: 342-344
12. Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606
13. Honda R, Yasuda H (1999) Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 18: 22-27
14. Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higashimoto Y, Appella E, Yao TP (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21: 6236-6245
15. Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E, Yao TP (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20: 1331-1340
16. Jensen K, Shiels C, Freemont PS (2001) PML protein isoforms and the RBCC/TRIM motif. Oncogene 20: 7223-7233
17. Joazeiro CA, Weissman AM (2002) RING finger proteins: mediators of ubiquitin ligase activity. Cell 102: 549-552
18. Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Lin YS, Wu CW (2000) Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem 275: 20436-20443
19. Kawai H, Wiederschain D, Kitao H, Stuart J, Tsai KK, Yuan ZM (2003a) DNA damage-induced MDMX degradation is mediated by MDM2. J Biol Chem 278: 45946-45953
20. Kawai H, Wiederschain D, Yuan ZM (2003b) Critical contribution of the MDM2 acidic domain to p53 ubiquitination. Mol Cell Biol 23: 4939-4947
21. Kobet E, Zeng X, Zhu Y, Keller D, Lu H (2002) MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins. Proc Natl Acad Sci USA 97: 12547-12552
22. Li M, Luo J, Brooks CL, Gu W (2002) Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277: 50607-50611
23. Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3: 577-587
24. Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM (1999) RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci USA 96: 11364-11369
25. Lu W, Lin J, Chen J (2002) Expression of p14ARF overcomes tumor resistance to p53. Cancer Res 62: 1305-1310
26. Luo J, Su F, Chen D, Shiloh A, Gu W (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381
27. Ma Y, Yuan J, Huang M, Jove R, Cress WD (2003) Regulation of the cyclin D3 promoter by E2F1. J Biol Chem 278: 16770-16776
28. Marechal V, Elenbaas B, Piette J, Nicolas J, Levine AJ (1994) The ribosomal LS protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol 14: 7414-7420
29. McMasters KM, Montes de Oca Luna R, Pena JR, Lozano G (1996) mdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts. Oncogene 13: 1731-1736
30. Meulmeester E, Frenk R, Stad R, De Graaf P, Marine JC, Vousden KH, Jochemsen AG (2003) Critical role for a central part of Mdm2 in the ubiquitylation of p53. Mol Cell Biol 23: 4929-4938
31. Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP (2001) An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19: 2312-2323
32. Pan Y, Chen J (2003) MDM2 promotes ubiquitination and degradation of MDMX. Mol Cell Biol 23: 5113-5121
33. Peng H, Begg GE, Schultz DC, Friedman JR, Jensen DE, Speicher DW, Rauscher FJ (2000) Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions. J Mol Biol 295: 1139-1162
34. Pham AD, Sauer F (2000) Ubiquitin-activating/conjugating activity of TAFII250, a mediator of activation of gene expression in Drosophila. Science 289: 2357-2360
35. Prives C, Hall PA (1999) The p53 pathway. J Pathol 187: 112-126
36. Rodriguez MS, Desterro JM, Lain S, Lane DP, Hay RT (2002) Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol Cell Biol 20: 8458-8467
37. Ryan RF, Schultz DC, Ayyanathan K, Singh PB, Friedman JR, Fredericks WJ, Rauscher FJ (1999) KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Kruppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing. Mol Cell Biol 19: 4366-4378
38. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ (2002) SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16: 919-932
39. Schultz DC, Friedman JR, Rauscher FJ (2001) Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD. Genes Dev 15: 428-443
40. Shvarts A, Steegenga WT, Riteco N, van Larr T, Dekker P, Bazuine M, van Ham RCA, van Oordt WVDH, Hateboer G, van der Eb AJ, Jochemsen AG (1996) MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J 15: 5349-5357
41. Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR, Shi Y (2004) Yin Yang 1 is a negative regulator of p53. Cell 117: 859-872
42. Urano T, Saito T, Tsukui T, Fujita M, Hosoi T, Muramatsu M, Ouchi Y, Inoue S (2002) Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 417: 871-875
43. Vousden KH (2000) p53: death star. Cell 103: 691-694
44. Wang X, Taplick J, Geva N, Oren M (2004) Inhibition of p53 degradation by Mdm2 acetylation. FEBS Lett 561: 195-201
45. Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, Xiong Y (2003) Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 23: 8902-8912
46. Zhang Y, Xiong Y (2001) Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ 12: 175-186